Warner Bros. Discovery, Inc.
Biphenyl compound as CCR2/CCR5 receptor antagonist
Last updated:
Abstract:
Provided is a CCR2/CCR5 receptor antagonist and the use thereof in the preparation of a drug for treating diseases associated with the CCR2/CCR5. In particular, disclosed are a compound represented by formula (I) and a pharmaceutically acceptable salt thereof. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
11 Dec 2017
Issue date:
26 Oct 2021